For Manuscript Submission, Check or Review Login please go to Submission Websites List.
For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.
Utility of Early MRI in the Diagnosis and Management of Acute Spontaneous Intracerebral HemorrhageWijman C.A.C.a, b · Venkatasubramanian C.a, b · Bruins S.b · Fischbein N.c · Schwartz N.a, b
aDepartment of Neurology and Neurological Sciences and bthe Stanford Stroke Center, and cDepartment of Radiology, Stanford University, Palo Alto, Calif., USA Corresponding Author
Christine A.C. Wijman, MD, PhD
Department of Neurology and Neurological Sciences and the Stanford Stroke Center
701 Welch Road, B325
Palo Alto, CA 94034 (USA)
Tel. +1 650 723 4448, Fax +1 650 723 4451, E-Mail firstname.lastname@example.org
Background: The optimal diagnostic evaluation for spontaneous intracerebral hemorrhage (ICH) remains controversial. In this retrospective study, we assessed the utility of early magnetic resonance imaging (MRI) in ICH diagnosis and management. Methods: Eighty-nine (72%) of 123 patients with spontaneous ICH underwent a brain CT and MRI within 30 days of ICH onset. Seventy patients with a mean age of 62 ± 15 years were included. A stroke neurologist and a general neurologist, each blinded to the final diagnosis, independently reviewed the admission data and the initial head CT and then assigned a presumed ICH cause under 1 of 9 categories. ICH cause was potentially modified after subsequent MRI review. The final ‘gold standard’ ICH etiology was determined after review of the complete medical record by an independent investigator. Change in diagnostic category and confidence and the potential impact on patient management were systematically recorded. Results: Mean time to MRI was 3 ± 5 days. Final ICH diagnosis was hypertension or cerebral amyloid angiopathy (CAA) in 50% of patients. After MRI review the stroke neurologist changed diagnostic category in 14%, diagnostic confidence in an additional 23% and management in 20%, and the general neurologist did so in 19, 21 and 21% of patients, respectively. MRI yield was highest in ICH secondary to ischemic stroke, CAA, vascular malformations and neoplasms, and did not differ by age, history of hypertension, hematoma location or the presence of intraventricular hemorrhage. Conclusions: The results of this study suggest potential additive clinical benefit of early MRI in patients with spontaneous ICH.
© 2010 S. Karger AG, Basel
Spontaneous (i.e. nontraumatic) intracerebral hemorrhage (ICH) accounts for at least 10–20% of strokes worldwide . Common etiologies are long-standing hypertension and cerebral amyloid angiopathy (CAA) [2,3], but there are multiple other causes including vascular malformations , aneurysms, tumors, coagulopathy, cerebral venous thrombosis, hemorrhagic transformation of an ischemic infarct, illicit drug use , endocarditis, moyamoya disease  and vasculitis, among others.
Identification of the cause of ICH used to be based on clinical evaluation supported by brain computed tomography (CT) with or without conventional catheter angiography (CA) [7,8]. It has been shown in recent years that magnetic resonance imaging (MRI) is just as sensitive as CT in the detection of acute brain hemorrhage [9,10,11,12] and more sensitive than CT in the detection of structural abnormalities [13,14,15,16,17]. While MRI has substantially improved our diagnostic capabilities, there are hardly any studies that have systematically evaluated its clinical effectiveness in ICH patients.
In this retrospective study we aimed to assess the clinical utility of early MRI in the diagnosis and management of ICH in a consecutive series of patients over a 5-year period at a single institution. The hypothesis was that MRI would be superior to CT in the diagnostic evaluation of patients presenting with a spontaneous ICH, and that this additional information would translate into a change in patient management.
The Stanford Stroke Center database was reviewed for all patients with the diagnosis of ICH between January 1999 and February 2004. Patients were included if they had a diagnosis of spontaneous intraparenchymal or isolated intraventricular hemorrhage (IVH) and if they had undergone a brain CT and MRI within 30 days of symptom onset at our institution. The study protocol was approved by the Stanford University Medical Human Subjects Panel.
Brain MRIs were obtained on a 1.5-tesla GE Signa Horizon NV/i scanner (EXCITE III) equipped with cardiac-enhanced gradients (40 mT/m). The following sequences were routinely obtained: T1- (sagittal) and T2-weighted imaging (axial), T2*-weighted gradient echo MRI, diffusion-weighted imaging (DWI), fluid-attenuated inversion recovery and 3-dimensional time-of-flight magnetic resonance angiography of the circle of Willis. T1-weighted imaging with contrast and 3-dimensional time-of-flight magnetic resonance venography were obtained in some patients.
Admission and inpatient medical records were reviewed by one investigator, and the following information was documented on a standardized data form: age, sex, ethnicity, succinct history of present illness, history of hypertension, stroke or transient ischemic attack, atrial fibrillation, clotting disorders, renal failure, alcohol abuse, malignancy, diabetes mellitus, illicit drug use, smoking, home medications, pertinent family history including stroke, vascular malformations and bleeding disorders, and admission physical and neurological examination. Laboratory results including complete blood cell count, coagulation profile, comprehensive chemistry panel, urine toxicity screen and admission EKG results were also recorded. Patients were considered to have a history of hypertension when 1 of the following 3 criteria was met: well-documented history of hypertension, treatment with antihypertensive agents as an outpatient, and left ventricular hypertrophy by EKG or echocardiography. Coagulopathy was defined as a platelet count of <50,000 cells/ml or an international normalized ratio of >3 or an activated partial thromboplastin time of >80 s.
A stroke and a general neurologist – both blinded to the patients’ clinical diagnoses and each other’s readings – independently reviewed each patient’s data form and the admission brain CT (including the neuroradiologist’s report) and recorded a presumed ICH cause under 1 of 9 predefined categories. In addition they recorded their diagnostic confidence as ‘possible’, ‘likely’ or ‘highly probable’. A potentially modified diagnosis or modified level of confidence was recorded after subsequent review of the brain MRI (which included the review of the neuroradiologist’s report). If either the diagnosis or the level of confidence changed after review of the MRI, the evaluator was asked to record which MRI sequences were most relevant for the change (up to 3 were allowed) and if and how the change in ICH etiology or confidence would affect patient management.
The study neurologists were instructed to consider only MRI findings that have been validated to be highly specific for the diagnosis in question based on pathological verification in previous studies. These included for example cerebral microbleeds in the deep gray nuclei or brainstem suggestive of long-standing hypertension  or cerebral microbleeds in the subcortical white matter in an elderly patient with a lobar ICH suggestive of CAA [3,16]. Hemorrhagic transformation of an ischemic stroke was considered if areas of restricted diffusion substantially exceeded the commonly seen perihemorrhagic diffusion artifacts or if there was presence of additional areas of restricted diffusion in other vascular territories in a patient with a compelling reason to suffer ischemic strokes (e.g. atrial fibrillation).
The final presumed ICH diagnosis or ‘the gold standard diagnosis’ was recorded by an independent investigator who was blinded to the diagnoses generated by the two study neurologists. This final diagnosis was determined after review of all available clinical, pathological and radiological data including clinic or imaging follow-up and typically corresponded to the clinical impression of the treating stroke neurologist(s) who cared for the patient. The CT and the MRI diagnoses of the study investigators were compared with this ‘gold standard’ diagnosis to determine whether the MRI added accuracy or certainty to the diagnostic impression. Credit for increased confidence was given only if diagnostic category did not change.
Data analyses were performed using the SPSS 17.0 software package (SPSS, Chicago, Ill., USA). χ2 and Fisher’s exact tests were used to analyze cross-categorized frequency data. All statistical tests were two-tailed, and statistical significance was defined at α < 0.05.
During the study period, 89 (72%) of 123 patients treated by the stroke service with a diagnosis of ICH had undergone both brain CT and MRI at our institution. Of these, 70 patients with a mean age of 62 ± 15 years are included in this report. Reasons for study exclusion were: the patient had a known ICH cause prior to admission (e.g. known untreated vascular malformation; n = 17) or the MRI was performed more than 30 days after the initial presentation (n = 2).
Patient characteristics are shown in table 1. The mean time between symptom onset and the MRI was 3 ± 5.4 days. Of the 70 patients, 46 had contrast-enhanced T1-weighted imaging, and 6 patients had magnetic resonance venography in addition to the routine sequences listed above. Seventy-nine percent of hematomas were supratentorial. Twenty-four patients (34%) had IVH; of these, 5 had isolated IVH. Seven patients had multiple hematomas, and 9 had associated subarachnoid hemorrhage shown by CT.
The final ICH cause was classified into 1 of 9 predefined categories based on the ‘gold standard’ as described above (table 2). Half of the patients had ICH attributed to either long-standing hypertension (36%) or CAA (14%). The MRI also helped identify other etiologies of spontaneous ICH such as vasculitis or hyperperfusion syndrome in 9 (13%) patients. The ICH cause was considered unknown in 11% of patients despite extensive diagnostic workup, which included additional contrast CT, CT angiography and CA in most of these patients.
Twelve patients (17%) had surgical evacuation of their hematomas, and a definite pathological diagnosis was obtained in 9 (brain tumor in 3 and vascular malformation in 6 patients). Eight of the 9 patients had been diagnosed correctly by preoperative MRI, including 1 patient with an arteriovenous malformation who earlier had a negative CA. An additional 15 patients (21%) underwent CA. Of these, 3 revealed a vascular malformation and 2 showed changes suggestive of a vasculitis or vasculopathy. In all instances, a preangiogram MRI/magnetic resonance angiography had correctly identified these findings. Thus, when assessing the diagnostic yield of MRI in this subset of 27 patients who had their ICH cause determined either by pathology and/or conventional CA, MRI had a sensitivity (and negative predictive value) of 93% (confidence interval 64–99) and a specificity (and positive predictive value) of 100% (confidence interval 73–100).
Both the stroke and the general neurologist were more likely to reach the reference ‘gold standard’ ICH diagnosis after reviewing the MRI. The stroke neurologist changed diagnostic category to the correct final diagnosis in 10 (14%) patients and the general neurologist in 13 (19%) patients after review of the MRI. In 60% of cases, the change was prompted by features on the MRI remote from the index bleed (e.g. the presence of microhemorrhages in other brain regions). Diagnostic confidence also increased after MRI review both for the stroke neurologist (16 patients, 23%) and the general neurologist (15 patients, 21%). Thus, the overall diagnostic yield of early MRI was 37% for the stroke neurologist and 40% for the general neurologist. Two patient examples are shown in figures 1 and 2. In one patient, MRI review changed the diagnostic impression from ‘possible brain tumor’ to ‘hemorrhage secondary to CAA’ (fig. 1). In the other patient, MRI review changed the diagnostic impression from ‘ICH caused by long-standing hypertension’ to ‘ICH secondary to a vascular malformation (i.e. cavernous angioma’; fig. 2). In 4 patients (6%), the general neurologist changed the diagnostic category incorrectly after MRI review. In 3 of these this was caused by interpreting a thin rim of perihematomal restricted diffusion (caused by artifact from blood products) as evidence for hemorrhagic transformation of an ischemic stroke. This did not occur for the stroke neurologist.
The diagnostic yield of MRI did not differ with age, sex, hypertension or the presence of associated subarachnoid hemorrhage or IVH (table 3). Furthermore, the yield was similar for patients with a ‘typical’ hypertensive ICH (i.e. patients with a history of hypertension who presented with an ICH in the basal ganglia, thalamus or posterior fossa) and those with an ‘atypical ICH’ (lobar or isolated IVH or multiple hematomas or absence of hypertension; 35 vs. 41%; p = NS). In addition, we did not observe a decrease in diagnostic yield of MRI in patients with a ‘typical ICH’ and older age (table 3). Thus, even in the subset of patients with a ‘classic’ hypertensive ICH, acute MRI changed either the initial diagnostic impression or the diagnostic confidence in 35% of patients.
Eighteen patients had an additional MRI in the chronic phase of the ICH (i.e. beyond 60 days). Three of these had an ICH of ‘unknown’ etiology after the initial MRI. In 2 of these patients, the final diagnosis was changed after the chronic MRI to CAA and vascular malformation based on interval development of numerous subcortical microbleeds in one and detection of an arteriovenous malformation after hematoma resorption in the other.
The general neurologist and the stroke neurologist reported that the additional information obtained from the MRI would have affected their patient management in 21 and 20% of patients, respectively. Such changes included decisions about (a) withholding or restarting antiplatelet or anticoagulation therapy, (b) degree of blood pressure control (e.g. tighter blood pressure control in a patient with an untreated vascular malformation), and (c) decisions regarding the need for further diagnostic workup (e.g. in patients for whom MRI review resulted in increased diagnostic confidence, unnecessary additional diagnostic workup could be avoided). The impact of MRI on patient management was particularly high in patients with ICH attributed to hemorrhagic transformation of an ischemic stroke, CAA, vascular malformations or neoplasms (table 2). The relative impact of individual MRI sequences is shown in table 4. The gradient echo, fluid-attenuated inversion recovery and DWI sequences were used most frequently in the decision making to change diagnostic category, diagnostic confidence or management.
Despite the proven superior sensitivity of MRI in the detection of structural brain lesions as compared to CT, it remains unclear whether MRI affects the diagnostic impression or management of ICH patients. Current guidelines on ICH management do not provide specific recommendations regarding the diagnostic workup of ICH because of the paucity of data [18,19]. One retrospective study used predefined criteria to determine whether MRI provided new diagnostic information in ICH . MRI was obtained in 23% of patients and provided a new diagnosis in 22% of these. A limitation of that study, however, was that MRIs were obtained only in 23% of all ICH patients, potentially overestimating its yield. Another retrospective study including 47 patients reported a diagnostic yield of MRI of 36% . Neither study assessed the potential impact of MRI on patient management.
The results of our study suggest a meaningful clinical benefit of routine brain MRI performed within the first week following symptom onset in patients with a spontaneous ICH or isolated IVH. Based on the MRI findings, diagnostic category or confidence was changed in more than one third of patients (27/70 = 39%). Furthermore, the MRI findings were judged to affect management decisions in one fifth of patients. The benefit of MRI appeared similar for the stroke expert and the general neurologist.
The patients in our study were consecutive patients identified from our stroke database over a 5-year time period. During this time 34 of 123 ICH patients did not undergo MRI at our institution. We did not record why these patients did not have MRI. It is possible that this group was different from the study cohort and that the yield of MRI would have been different. However, even if we assumed a ‘worst case’ scenario (the diagnostic yield of MRI in the 53 patients who were not included in our data set could have been 0%), the overall diagnostic yield of MRI in our study would still have been 22%, which we believe is clinically relevant.
The results of our study suggest that the routine use of MRI may be beneficial in all spontaneous ICH patients. The clinical yield of MRI was noted in every etiological category, but was highest in patients with ICH attributed to ischemic stroke, CAA, vascular malformation or neoplasm. This finding is consistent with a previous study showing that CAA and vascular malformations were the etiologies most frequently identified by MRI . It should be kept in mind that in ICH due to a neoplasm, obtaining MRI within the first 3 days may help avoid masking of tumor characteristics by methemoglobin that is present in the subacute phase.
We did not observe a substantial differential diagnostic yield of MRI based on patient age, presence of hypertension or hematoma location. Even in the subset of patients with a ‘classic’ hypertensive ICH, MRI changed either the initial diagnostic impression or confidence in 35%. This finding is different from prior studies looking at the utility of CA in deep ICH [8,21]; however, the diagnostic yield of MRI as measured in this study goes beyond identifying an underlying vascular abnormality. MRI can reveal causes for ICH based on findings in the brain parenchyma that cannot be identified on vessel-only imaging studies (e.g. tumors, cerebral infarction and tissue changes consistent with CAA and chronic hypertension) [13,20]. Furthermore, with only a limited number of patients in each subgroup, we may not have detected a real difference.
The MRI sequences with the greatest yield were gradient echo, fluid-attenuated inversion recovery and DWI which should be included in all ICH patients who undergo MRI [13,20]. More advanced MRI technologies, notably those using parallel imaging, will likely overcome some of the limitations of conventional DWI (low spatial resolution, image distortion near paranasal sinuses and skull base, and magnetic susceptibility artifacts due to blood products), further enhancing the utility of MRI in spontaneous ICH [22,23,24,25,26,27].
It has been reported that the large majority of spontaneous ICHs are ‘primary’, i.e. caused either by long-standing hypertension or CAA or both [28,29]. Some autopsy series, however, have not confirmed this observation . In this study, only half of the patients had a final diagnosis of ICH due to hypertension and/or CAA. It is possible that our patient population in a tertiary referral center does not reflect the typical distribution of ICH etiologies due to a referral bias. Furthermore, our study population may not be a representative sample of all ICH patients seen at our institution during the study period since not all spontaneous ICH patients had undergone MRI during that time. Alternatively, it is conceivable that the frequent use of MRI in ICH patients at our institution unmasks secondary hemorrhage causes in patients whose hematomas would have otherwise been attributed to a ‘primary’ cause. The patient in figure 2 is one such example. Based on the history and location of the ICH on the CT scan, the ICH was initially attributed to long-standing hypertension until the MRI showed an underlying cavernous angioma. Thus, MRI in this patient affected diagnosis and management. The patient underwent surgical resection of the cavernous angioma to prevent recurrent ICH.
One of the limitations of this study is the validity of the reference standard, which incorporated the results of the MRI. We decided to base our reference standard on the ICH etiology determined by an independent investigator after review of all the available patient information including medical records, CT imaging, MRI, cerebral angiograms, laboratory results, other diagnostic tests, pathology and patient follow-up. Certainly, a gold standard based on brain pathology and/or CA would have been preferable, but this was not feasible in most cases. It is reassuring, however, that in the subset of 27 patients in whom ICH etiology was confirmed by pathology or CA, the sensitivity and specificity of MRI for ICH cause was 93 and 100%, respectively. One other limitation of this study is its retrospective nature and its results should be interpreted within the limits of such a study design. Further, our study design does not allow for the assessment of the practical aspects of obtaining routine MRI in ICH patients or for assessing changes in patient outcome based on MRI-related changes in diagnosis or management. In addition, MRI yield was determined after review of noncontrast CT. Potentially more sensitive CT imaging techniques including contrast-enhanced CT and CT angiography will likely impact the diagnostic yield of MRI in ICH patients [31,32]. Finally, it is possible that the diagnostic yield of MRI may be different in the chronic phase after resorption of the hematoma. We were unable to address this issue since only a small number of our patients had repeat MRI in the chronic phase. As systematic data on the utility of chronic MRI in spontaneous ICH are lacking, this issue deserves further study.
C.A.C.W. is funded by NIH grants R01 NS034866-08 and R01 HL089116-01A2.
Christine A.C. Wijman, MD, PhD
Department of Neurology and Neurological Sciences and the Stanford Stroke Center
701 Welch Road, B325
Palo Alto, CA 94034 (USA)
Tel. +1 650 723 4448, Fax +1 650 723 4451, E-Mail email@example.com
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.